Risk of Post-COVID Conditions among adolescents and adults who received nirmatrelvir-ritonavir for acute COVID-19: a retrospective cohort study
Dalton et al., medRxiv, doi:10.1101/2025.05.30.25327809
https://c19early.org/dalton2.html